Mayo enters ASU research partnership
From staff reports
Mayo Clinic in Arizona and Arizona State University have formed a new cancer-research partnership called "MAC5," or Mayo Clinic-ASU Center for Cancer-related Convergence, Cooperation and Collaboration, says a statement from The Biodesign Institute at ASU.
The center will be housed on the Mayo Clinic campus in Scottsdale in the Mayo Clinic Collaborative Research Building, which also houses biotech companies TGEN, or Translational Genomics Research Institute, and InNexus Biotechnology Inc.
In a similar way, Mayo in Rochester is trying to develop the biosciences through the Minnesota Partnership for Biotechnology and Medical Genomics with the University of Minnesota. In addition, efforts are under way by the city of Rochester to build a nine-story Minnesota Bioscience Development Center downtown.
In Arizona, doctors at the forefront of health care at Mayo will join scientists and engineers from ASU to accelerate cancer research.
"The openness and intellectual fusion of our educational, scientific, and cultural linkages are at the early stages of what we hope to be a significant and profound relationship to improve health care," ASU President Michael M. Crow said in a statement from ASU's Biodesign Institute.
"With ASU, we are now just scratching the surface of a great opportunity to work together with scientists, clinicians and patients," said Dr. Victor Trastek, chair of the Mayo Arizona Board of Governors. "This type of collaborative effort is the future in caring for patients and developing new types of science, devices and therapeutics to advance medicine."
The "ambitious goal" of the collaboration is "to revolutionize medical practices for cancer-related diseases" by shifting to an "earlier, preventative and individualized approach to medical care," said George Poste, director of the Biodesign Institute.
The collaboration is the largest ever between Mayo and ASU.